COMMUNIQUÉS West-GlobeNewswire

-
BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results
29/04/2024 -
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
29/04/2024 -
Cellectis publie ses résultats financiers du quatrième trimestre 2023 et de l’exercice 2023
29/04/2024 -
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
29/04/2024 -
Travere Therapeutics to Report First Quarter 2024 Financial Results
29/04/2024 -
Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
29/04/2024 -
ARCPOINT TO HOST CONFERENCE CALL TO DISCUSS 2023 Q4 AND FULL YEAR FINANCIAL RESULTS
29/04/2024 -
Streamline Health® Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results
29/04/2024 -
Better Choice Company Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
29/04/2024 -
OpGen Provides Update on Business Operations and Strategic Opportunities
29/04/2024 -
Option Care Health to Participate in the BofA Securities Health Care Conference
29/04/2024 -
ACELYRIN, INC. to Report First Quarter 2024 Financial Results and Corporate Update on May 13, 2024
29/04/2024 -
GeneDx Reports First Quarter 2024 Financial Results and Business Highlights
29/04/2024 -
Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation
29/04/2024 -
Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Friday, May 10, 2024
29/04/2024 -
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
29/04/2024 -
Oculis Publishes Invitation to the Annual General Meeting
29/04/2024 -
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
29/04/2024 -
Teknova to Report First Quarter 2024 Financial Results on May 13, 2024
29/04/2024
Pages